GlassScriptPhysician profile
Catherine Eb Schwender
NPI 1174628127
$5,499.57
in general payments reported to CMS, 2019-2025
45 companies · $1,778 in 2025
The $1,778 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $313 · 2021: $817 · 2022: $825 · 2023: $381 · 2024: $560 · 2025: $1,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,375 · Travel and Lodging: $247 · Education: $97.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,375.20 |
| Travel and Lodging | $246.92 |
| Education | $97.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $807.83 | 2022-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $750.22 | 2019-2025 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $436.64 | 2019-2025 | |
| Janssen Biotech, INC. | $417.79 | 2020-2023 | Erleada |
| Abbvie INC. | $321.80 | 2019-2025 | Botox |
| Ferring Pharmaceuticals INC. | $277.64 | 2024-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $230.48 | 2019-2024 | Provenge |
| Myriad Genetic Laboratories, INC. | $210.88 | 2021-2024 | Prolaris |
| Pfizer INC. | $206.42 | 2019-2021 | |
| Medtronic, INC. | $166.26 | 2025 | Interstim |
| Boston Scientific Corporation | $161.43 | 2019-2025 | General - Kidney Stone Disease, Spaceoar Vue System - 10ml, Lithovue |
| Allergan, INC. | $130.71 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $118.32 | 2024 | Bard Urinary Drainage Bag |
| Endo Pharmaceuticals INC. | $111.93 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $96.65 | 2022-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Schwender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.